Improvement of behavioural pattern and alpha-synuclein levels in autism spectrum disorder after consumption of a beta-glucan food supplement in a randomized, parallel-group pilot clinical study
Kadalraja Raghavan, Vidyasagar Devaprasad Dedeepiya, Nobunao Ikewaki, Tohru Sonoda, Masaru Iwasaki, Senthilkumar Preethy, View ORCID ProfileSamuel JK Abraham
doi: https://doi.org/10.1101/2021.06.28.21259619
Kadalraja Raghavan
1Department of Paediatric Neurology, Kenmax Medical Service Private Limited, Madurai, India
2Department of Paediatric Neurology, Sarvee Integra Private Limited, Chennai, India
Vidyasagar Devaprasad Dedeepiya
3The Mary-Yoshio Translational Hexagon (MYTH), Nichi-In Centre for Regenerative Medicine (NCRM), Chennai, India
Nobunao Ikewaki
4Dept. of Medical Life Science, Kyushu University of Health and Welfare, Japan
5Institute of Immunology, Junsei Educational Institute, Nobeoka, Miyazaki, Japan
Tohru Sonoda
5Institute of Immunology, Junsei Educational Institute, Nobeoka, Miyazaki, Japan
Masaru Iwasaki
6Centre for Advancing Clinical Research (CACR), University of Yamanashi - School of Medicine, Chuo, Japan
Senthilkumar Preethy
7The Fujio-Eiji Academic Terrain (FEAT), Nichi-In Centre for Regenerative Medicine (NCRM), Chennai, India
Samuel JK Abraham
3The Mary-Yoshio Translational Hexagon (MYTH), Nichi-In Centre for Regenerative Medicine (NCRM), Chennai, India
6Centre for Advancing Clinical Research (CACR), University of Yamanashi - School of Medicine, Chuo, Japan
8Antony- Xavier Interdisciplinary Scholastics (AXIS)GN Corporation Co. Ltd., Kofu, Japan
Article usage
Posted June 29, 2021.
Improvement of behavioural pattern and alpha-synuclein levels in autism spectrum disorder after consumption of a beta-glucan food supplement in a randomized, parallel-group pilot clinical study
Kadalraja Raghavan, Vidyasagar Devaprasad Dedeepiya, Nobunao Ikewaki, Tohru Sonoda, Masaru Iwasaki, Senthilkumar Preethy, Samuel JK Abraham
medRxiv 2021.06.28.21259619; doi: https://doi.org/10.1101/2021.06.28.21259619
Improvement of behavioural pattern and alpha-synuclein levels in autism spectrum disorder after consumption of a beta-glucan food supplement in a randomized, parallel-group pilot clinical study
Kadalraja Raghavan, Vidyasagar Devaprasad Dedeepiya, Nobunao Ikewaki, Tohru Sonoda, Masaru Iwasaki, Senthilkumar Preethy, Samuel JK Abraham
medRxiv 2021.06.28.21259619; doi: https://doi.org/10.1101/2021.06.28.21259619
Subject Area
Subject Areas
- Addiction Medicine (316)
- Allergy and Immunology (621)
- Anesthesia (162)
- Cardiovascular Medicine (2298)
- Dermatology (202)
- Emergency Medicine (371)
- Epidemiology (11623)
- Forensic Medicine (10)
- Gastroenterology (683)
- Genetic and Genomic Medicine (3629)
- Geriatric Medicine (341)
- Health Economics (622)
- Health Informatics (2332)
- Health Policy (919)
- Hematology (336)
- HIV/AIDS (758)
- Medical Education (361)
- Medical Ethics (101)
- Nephrology (394)
- Neurology (3390)
- Nursing (193)
- Nutrition (512)
- Oncology (1777)
- Ophthalmology (526)
- Orthopedics (211)
- Otolaryngology (284)
- Pain Medicine (226)
- Palliative Medicine (66)
- Pathology (441)
- Pediatrics (1013)
- Primary Care Research (410)
- Public and Global Health (6021)
- Radiology and Imaging (1238)
- Respiratory Medicine (814)
- Rheumatology (370)
- Sports Medicine (319)
- Surgery (390)
- Toxicology (50)
- Transplantation (171)
- Urology (143)